PMCB

PMCB

USD

PharmaCyte Biotech Inc. Common Stock

$0.890-0.010 (-1.111%)

Preço em tempo real

Healthcare
Biotecnologia
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$0.900

Máximo

$0.917

Mínimo

$0.880

Volume

0.00M

Fundamentos da empresa

Capitalização de mercado

6.0M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

0.10M

Bolsa de valores

NCM

Moeda

USD

Faixa de 52 semanas

Mínimo $0.8Atual $0.890Máximo $1.94

Notícias relacionadas

BusinessWire

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

TNF new strategic partner LightSolver named a 2025 World Economic Forum Technology Pioneer and recognized in Gartner's 2025 Hype Cycle for Data Center Infrastructure Technologies PharmaCyte Biotech, Inc. (NASDAQ:PMCB)

Ver mais
PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications
BusinessWire

PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing

PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company"), today announced the closing of its previously announced $7 million financing. As of April 30, 2025, PharmaCyte had approximately $15.5 million in

Ver mais
PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing
BusinessWire

PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company") announced today that it has entered into a securities purchase agreement for a $7.0 million financing with existing investors involving the sale of

Ver mais
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.